Literature DB >> 8897805

Adenine nucleotide diphosphates: emerging second messengers acting via intracellular Ca2+ release.

T P Dousa1, E N Chini, K W Beers.   

Abstract

Release of Ca2+ from intracellular stores is a widespread mechanism in regulation of cell function. Two hitherto unknown adenine diphosphonucleotides were recently identified, which trigger Ca2+ release from intracellular stores via channels that are distinct from the well-known receptor/channel controlled by inositol 1,4,5,-trisphosphate (IP3): cyclic ADP-ribose (cADPR) and nicotinic acid adenine dinucleotide phosphate (NAADP). Here we review synthesis of cADPR from beta-NAD, its hydrolysis to adenosine diphosphoribose (noncyclic) by cADPR glycohydrolase, as well as our knowledge about the metabolism of NAADP. The Ca2+ release triggered by cADPR, NAADP, or IP3 can be distinguished by the action of inhibitors and by desensitization studies. Evidence now emerges that cADPR synthesis from beta-NAD can be stimulated, at least in some cell types by all-trans-retinoic acid as a first messenger. We then review the properties of cADPR and NAADP as potential second messengers in the intracrine regulation of cell functions. Although their exact role in signaling sequences is not yet known, cADPR and NAADP are likely to play important intracellular regulatory functions, as extensively documented for the process of egg fertilization.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8897805     DOI: 10.1152/ajpcell.1996.271.4.C1007

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  22 in total

1.  Distinct Ca(2+) signalling mechanisms induced by ATP and sphingosylphosphorylcholine in porcine aortic smooth muscle cells.

Authors:  T Y Chin; S H Chueh
Journal:  Br J Pharmacol       Date:  2000-04       Impact factor: 8.739

Review 2.  Calcium at fertilization and in early development.

Authors:  Michael Whitaker
Journal:  Physiol Rev       Date:  2006-01       Impact factor: 37.312

3.  CD38 expression, function, and gene resequencing in a human lymphoblastoid cell line-based model system.

Authors:  William R Hartman; Linda L Pelleymounter; Irene Moon; Krishna Kalari; Mohan Liu; Tse-Yu Wu; Carlos Escande; Veronica Nin; Eduardo N Chini; Richard M Weinshilboum
Journal:  Leuk Lymphoma       Date:  2010-07

4.  Characterization of CD38 in the major cell types of the heart: endothelial cells highly express CD38 with activation by hypoxia-reoxygenation triggering NAD(P)H depletion.

Authors:  James Boslett; Craig Hemann; Fedias L Christofi; Jay L Zweier
Journal:  Am J Physiol Cell Physiol       Date:  2017-11-29       Impact factor: 4.249

Review 5.  Multifunctional roles of NAD⁺ and NADH in astrocytes.

Authors:  Franziska Wilhelm; Johannes Hirrlinger
Journal:  Neurochem Res       Date:  2012-04-03       Impact factor: 3.996

6.  CD38 is the major enzyme responsible for synthesis of nicotinic acid-adenine dinucleotide phosphate in mammalian tissues.

Authors:  Eduardo N Chini; Claudia C S Chini; Ichiro Kato; Shin Takasawa; Hiroshi Okamoto
Journal:  Biochem J       Date:  2002-02-15       Impact factor: 3.857

7.  InsP3, but not novel Ca2+ releasers, contributes to agonist-initiated contraction in rabbit airway smooth muscle.

Authors:  K Iizuka; A Yoshii; K Dobashi; T Horie; M Mori; T Nakazawa
Journal:  J Physiol       Date:  1998-09-15       Impact factor: 5.182

Review 8.  The secret life of NAD+: an old metabolite controlling new metabolic signaling pathways.

Authors:  Riekelt H Houtkooper; Carles Cantó; Ronald J Wanders; Johan Auwerx
Journal:  Endocr Rev       Date:  2009-12-09       Impact factor: 19.871

Review 9.  CD38 as a regulator of cellular NAD: a novel potential pharmacological target for metabolic conditions.

Authors:  Eduardo Nunes Chini
Journal:  Curr Pharm Des       Date:  2009       Impact factor: 3.116

10.  Differential effect of pH upon cyclic-ADP-ribose and nicotinate-adenine dinucleotide phosphate-induced Ca2+ release systems.

Authors:  E N Chini; M Liang; T P Dousa
Journal:  Biochem J       Date:  1998-11-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.